A UF College of Pharmacy researcher team led by Dr. Hendrik Luesch recently developed a novel molecule based on marine cyanobacteria, Apra S10, to target pancreatic cancer cells.
With the funding from the Maximizing Investigators’ Research Award, Ding aims to access and expand chemical diversity of microbes through the use of new, innovative strategies.
Known as the Maximizing Investigators’ Research Award, the grant will fund several of Huigens’ research projects, including efforts to develop compounds that will eliminate bacterial biofilm-associated infections.
Led by principal investigator, Rob Huigens, Ph.D., an assistant professor of medicinal chemistry, the grant aims to establish a drug discovery pipeline to generate and identify new small molecules that possess anticancer activities.
Cisneros' poster ranked in the top 25 percent of all TL1 trainees presenting at the Association for Clinical and Translational Science Meeting.
The researchers found a more efficient way to harvest the UV-absorbing amino acid known as shinorine, which marine organisms like cyanobacteria and macroalgae produce.
Dr. Yousong Ding in the UF College of Pharmacy found the Coprinus comatus mushroom, commonly known as the lawyer’s wig or shaggy mane, killed human T-cell leukemia cells during laboratory tests.
A University of Florida research team investigating biofilm-eradication has landed on the cover of the Feb. 16 issue of ChemBioChem.
A record 89 poster entries and a keynote address about how technology is transforming clinical drug development highlighted the annual event.
Hendrik Luesch, Ph.D., a professor and chair of medicinal chemistry and the Debbie and Sylvia DeSantis Chair in Natural Products Drug Discovery and Development, received the Golden Medal Award for his presentation at the 2nd International Conference on Herbal and Traditional Medicine.